Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy
Diabetes · 2024
DOI: 10.2337/db23-0688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Yanli Miao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Autophagy, HSP20 Heat-Shock Proteins, Mitogen-Activated Protein Kinase 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Heat shock protein 20 (HSP20) emerges as a novel regulator of autophagy in the heart. Nonetheless, the detailed function of HSP20 in liver and its effect on autophagy remain unknown. Here, we observed that HSP20 expression is increased in liver tissues from mice and patients with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD). Liver-specific downregulation of HSP20 mitigates hepatic steatosis and insulin resistance in obese mice, while upregulating HSP20 promotes lipid deposition and hepatocyte cell death. Mechanistically, Liquid chromatography tandem mass spectrometry (LC-MS/MS) revealed that HSP20 interacts with phosphorylated extracellular regulated protein kinases 2 (ERK2) and prevents its dephosphorylation by dual specificity phosphatase 6 (DUSP6), leading to ERK2-mediated repression of autophagy, resulting in aggravated saturated fatty acid (SFA)-triggered hepatocyte death. Importantly, such adverse effects could be ameliorated by ERK inhibitor. Our data reveals a framework of how HSP20 increases susceptibility of SFA-induced liver injury through enhancing ERK2 phosphorylation, which represents a plausible therapeutic intervention to combat MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH.
- Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Jiangtong Peng, Kai Huang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Miao, Y., Zhong, Y., Li, Y., Qin, H., Yang, L., Cao, G., Tang, Y., Yu, T., Fan, D., Lu, Y., Peng, J., & Huang, K. (2024). Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy. Diabetes. https://doi.org/10.2337/db23-0688
Vancouver
Miao Y, Zhong Y, Li Y, Qin H, Yang L, Cao G, et al. Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy. Diabetes. 2024. doi:10.2337/db23-0688
BibTeX
@article{Miao2024,
author = {Miao, Yanli and Zhong, Yi and Li, Yutian and Qin, Haojie and Yang, Ling and Cao, Guojun and Tang, Yong and Yu, Ting and Fan, Di and Lu, Yang and Peng, Jiangtong and Huang, Kai},
title = {Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0688}
}
EUVIMED